{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:59:06Z","timestamp":1792425546186,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T00:00:00Z","timestamp":1640044800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012017","name":"University of Ghana Noguchi Memorial Institute for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["CDMRPL-19-0-PR180876"],"award-info":[{"award-number":["CDMRPL-19-0-PR180876"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XH-19-1-0020"],"award-info":[{"award-number":["W81XH-19-1-0020"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.vaccine.2021.12.042","type":"journal-article","created":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T07:27:02Z","timestamp":1640590022000},"page":"757-764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Towards large-scale identification of HLA-restricted T cell epitopes from four vaccine candidate antigens in a malaria endemic community in Ghana"],"prefix":"10.1016","volume":"40","author":[{"given":"Kwadwo Asamoah","family":"Kusi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebenezer Addo","family":"Ofori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwadwo","family":"Akyea-Mensah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Kyei-Baafour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustina","family":"Frimpong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana Aba","family":"Ennuson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Belmonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harini","family":"Ganeshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda Eva","family":"Amoah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Villasante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Sedegah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"52","key":"10.1016\/j.vaccine.2021.12.042_b0005","doi-asserted-by":"crossref","first-page":"7425","DOI":"10.1016\/j.vaccine.2015.09.061","article-title":"RTS, S: Toward a first landmark on the Malaria Vaccine Technology Roadmap","volume":"33","author":"Kaslow","year":"2015","journal-title":"Vaccine."},{"issue":"24","key":"10.1016\/j.vaccine.2021.12.042_b0010","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa0807381","article-title":"Efficacy of RTS, S\/AS01E vaccine against malaria in children 5 to 17 months of age","volume":"359","author":"Bejon","year":"2008","journal-title":"NEnglJMed."},{"issue":"7642","key":"10.1016\/j.vaccine.2021.12.042_b0015","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature21060","article-title":"Sterile protection against human malaria by chemoattenuated PfSPZ vaccine","volume":"542","author":"Mordm\u00fcller","year":"2017","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.vaccine.2021.12.042_b0020","first-page":"614","article-title":"Protection against malaria at 1 year and immune correlates following PfSPZ vaccination","volume":"22","author":"Ishizuka","year":"2016","journal-title":"NatMed."},{"key":"10.1016\/j.vaccine.2021.12.042_b0025","doi-asserted-by":"crossref","DOI":"10.1126\/science.1241800","article-title":"Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine","author":"Seder","year":"2013","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.vaccine.2021.12.042_b0030","first-page":"e1002389","article-title":"Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans","volume":"7","author":"Teirlinck","year":"2011","journal-title":"PLoSPathog."},{"issue":"2","key":"10.1016\/j.vaccine.2021.12.042_b0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2567.2011.03542.x","article-title":"Steric recognition of T-cell receptor contact residues is required to map mutant epitopes by immunoinformatical programmes","volume":"136","author":"Hsu","year":"2012","journal-title":"Immunology"},{"issue":"7","key":"10.1016\/j.vaccine.2021.12.042_b0040","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1182\/blood-2012-06-437202","article-title":"Peptide length determines the outcome of TCR\/peptide-MHCI engagement","volume":"121","author":"Ekeruche-Makinde","year":"2013","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.vaccine.2021.12.042_b0045","doi-asserted-by":"crossref","first-page":"5870","DOI":"10.4049\/jimmunol.0900302","article-title":"Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes","volume":"183","author":"Trimnell","year":"2009","journal-title":"JImmunol."},{"key":"10.1016\/j.vaccine.2021.12.042_b0050","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1126\/science.3085218","article-title":"Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon","volume":"232","author":"Ferreira","year":"1986","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.vaccine.2021.12.042_b0055","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00498-16","article-title":"The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking Vaccines","volume":"85","author":"Espinosa","year":"2017","journal-title":"Infect Immun."},{"key":"10.1016\/j.vaccine.2021.12.042_b0060","doi-asserted-by":"crossref","unstructured":"Chuang I, Sedegah M, Cicatelli S, Spring M, Polhemus M, Tamminga C, et al. DNA prime\/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity. PLoS ONE. 2013;8:e55571.","DOI":"10.1371\/journal.pone.0055571"},{"issue":"12","key":"10.1016\/j.vaccine.2021.12.042_b0065","doi-asserted-by":"crossref","first-page":"e0208328","DOI":"10.1371\/journal.pone.0208328","article-title":"First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5\u201317 months old infants and children","volume":"13","author":"Tiono","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.12.042_b0070","doi-asserted-by":"crossref","unstructured":"Trieu A, Kayala MA, Burk C, Molina DM, Freilich DA, Richie TL, et al. Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens. MolCell Proteomics. 2011;10:M111.","DOI":"10.1074\/mcp.M111.007948"},{"issue":"2","key":"10.1016\/j.vaccine.2021.12.042_b0075","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1084\/jem.20101488","article-title":"The malaria circumsporozoite protein has two functional domains, each with distinct roles as sporozoites journey from mosquito to mammalian host","volume":"208","author":"Coppi","year":"2011","journal-title":"J Exp Med."},{"issue":"9443","key":"10.1016\/j.vaccine.2021.12.042_b0080","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0140-6736(04)17223-1","article-title":"Efficacy of the RTS, S\/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial","volume":"364","author":"Alonso","year":"2004","journal-title":"Lancet"},{"issue":"26","key":"10.1016\/j.vaccine.2021.12.042_b0085","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1515257","article-title":"Seven-Year Efficacy of RTS, S\/AS01 Malaria Vaccine among Young African Children","volume":"374","author":"Olotu","year":"2016","journal-title":"N Engl J Med."},{"issue":"10","key":"10.1016\/j.vaccine.2021.12.042_b0090","first-page":"9490","article-title":"A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites","volume":"279","author":"Silvie","year":"2004","journal-title":"JBiolChem."},{"key":"10.1016\/j.vaccine.2021.12.042_b0095","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1083\/jcb.201206112","article-title":"The cellular and molecular basis for malaria parasite invasion of the human red blood cell","volume":"198","author":"Cowman","year":"2012","journal-title":"J Cell Biol."},{"issue":"3","key":"10.1016\/j.vaccine.2021.12.042_b0100","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/femsre\/fuw001","article-title":"Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria","volume":"40","author":"Beeson","year":"2016","journal-title":"FEMS Microbiol Rev."},{"issue":"17","key":"10.1016\/j.vaccine.2021.12.042_b0105","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1073\/pnas.1719660115","article-title":"Alpha-v-containing integrins are host receptors for the Plasmodium falciparum sporozoite surface protein","volume":"115","author":"Dundas","year":"2018","journal-title":"TRAP. ProcNatlAcadSci USA"},{"issue":"17","key":"10.1016\/j.vaccine.2021.12.042_b0110","doi-asserted-by":"crossref","first-page":"9952","DOI":"10.1073\/pnas.1633254100","article-title":"Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data","volume":"100","author":"Doolan","year":"2003","journal-title":"ProcNatlAcadSciUSA"},{"issue":"3","key":"10.1016\/j.vaccine.2021.12.042_b0115","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0092-8674(00)80511-5","article-title":"TRAP is necessary for gliding motility and infectivity of plasmodium sporozoites","volume":"90","author":"Sultan","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2021.12.042_b0120","first-page":"1","article-title":"HLA class I supertypes: a revised and updated classification","volume":"9","author":"Sidney","year":"2008","journal-title":"BMCImmunol."},{"issue":"6","key":"10.1016\/j.vaccine.2021.12.042_b0125","doi-asserted-by":"crossref","first-page":"e0199172","DOI":"10.1371\/journal.pone.0199172","article-title":"Seasonal variations in Plasmodium falciparum parasite prevalence assessed by varying diagnostic tests in asymptomatic children in southern Ghana","volume":"13","author":"Ayanful-Torgby","year":"2018","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.vaccine.2021.12.042_b0130","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3390\/genes10060434","article-title":"The Diversity, Multiplicity of Infection and Population Structure of P. falciparum Parasites Circulating in Asymptomatic Carriers Living in High and Low Malaria Transmission Settings of Ghana","volume":"10","author":"Abukari","year":"201910434","journal-title":"Genes."},{"issue":"1","key":"10.1016\/j.vaccine.2021.12.042_b0135","article-title":"Measurement of ex vivo ELISpot interferon-gamma recall responses to Plasmodium falciparum AMA1 and CSP in Ghanaian adults with natural exposure to malaria","volume":"15","author":"Ganeshan","year":"2016","journal-title":"MalarJ."},{"issue":"2","key":"10.1016\/j.vaccine.2021.12.042_b0140","doi-asserted-by":"crossref","first-page":"e0228177","DOI":"10.1371\/journal.pone.0228177","article-title":"Identification of Plasmodium falciparum circumsporozoite protein-specific CD8+ T cell epitopes in a malaria exposed population","volume":"15","author":"Kusi","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.12.042_b0145","doi-asserted-by":"crossref","unstructured":"Epstein JE, Paolino KM, Richie TL, Sedegah M, Singer A, Ruben AJ, et al. Protection against Plasmodium falciparum malaria by PfSPZ Vaccine. JCIInsight. 2017;2:e89154.","DOI":"10.1172\/jci.insight.89154"},{"issue":"24","key":"10.1016\/j.vaccine.2021.12.042_b0150","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1056\/NEJMoa0807773","article-title":"Safety and Immunogenicity of RTS, S\/AS02D Malaria Vaccine in Infants","volume":"359","author":"Abdulla","year":"2008","journal-title":"N Engl J Med."},{"issue":"11","key":"10.1016\/j.vaccine.2021.12.042_b0155","doi-asserted-by":"crossref","first-page":"e13838","DOI":"10.1371\/journal.pone.0013838","article-title":"Safety, Immunogenicity and Duration of Protection of the RTS, S\/AS02D Malaria Vaccine: One Year Follow-Up of a Randomized Controlled Phase I\/IIb Trial","volume":"5","author":"Aide","year":"2010","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.vaccine.2021.12.042_b0160","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1093\/infdis\/jiu293","article-title":"Cytotoxic Markers Associate With Protection Against Malaria in Human Volunteers Immunized With Plasmodium falciparum Sporozoites","volume":"210","author":"Bijker","year":"2014","journal-title":"J Infect Dis."},{"issue":"9779","key":"10.1016\/j.vaccine.2021.12.042_b0165","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/S0140-6736(11)60360-7","article-title":"Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study","volume":"377","author":"Roestenberg","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2021.12.042_b0170","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1073\/pnas.85.2.573","article-title":"CD8+ T cells (cytotoxic\/suppressors) are required for protection in mice immunized with malaria sporozoites","volume":"85","author":"Weiss","year":"1988","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2021.12.042_b0175","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.4049\/jimmunol.139.6.2020","article-title":"Interferon-gamma inhibits the intrahepatocytic development of malaria parasites in vitro","volume":"139","author":"Schofield","year":"1987","journal-title":"JImmunol."},{"key":"10.1016\/j.vaccine.2021.12.042_b0180","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cellimm.2017.05.001","article-title":"Frequent inoculations with radiation attenuated sporozoite is essential for inducing sterile protection that correlates with a threshold level of Plasmodia liver-stage specific CD8+ T cells","volume":"317","author":"Patel","year":"2017","journal-title":"Cell Immunol."},{"issue":"21","key":"10.1016\/j.vaccine.2021.12.042_b0185","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa1505819","article-title":"Genetic Diversity and Protective Efficacy of the RTS, S\/AS01 Malaria Vaccine","volume":"373","author":"Neafsey","year":"2015","journal-title":"NEnglJMed."},{"key":"10.1016\/j.vaccine.2021.12.042_b0190","doi-asserted-by":"crossref","unstructured":"Ouattara A, Takala-Harrison S, Thera MA, Coulibaly D, Niangaly A, Saye R, et al. Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications. JInfectDis. 2013;207:511\u20139.","DOI":"10.1093\/infdis\/jis709"},{"issue":"1","key":"10.1016\/j.vaccine.2021.12.042_b0195","first-page":"77","article-title":"Differential evidence of natural selection on two leading sporozoite stage malaria vaccine candidate antigens","volume":"37","author":"Weedall","year":"2007","journal-title":"IntJParasitol."},{"key":"10.1016\/j.vaccine.2021.12.042_b0200","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.meegid.2018.01.023","article-title":"Analysis of genetic diversity and population structure of gene encoding cell-traversal protein for ookinetes and sporozoites (CelTOS) vaccine candidate antigen in global Plasmodium falciparum populations","volume":"59","author":"Pirahmadi","year":"2018","journal-title":"Infect Genet Evol."},{"key":"10.1016\/j.vaccine.2021.12.042_b0205","doi-asserted-by":"crossref","unstructured":"R\u00e9nia L, Goh YS. Malaria Parasites: The Great Escape. Front Immunol. 2016;7.","DOI":"10.3389\/fimmu.2016.00463"},{"issue":"1","key":"10.1016\/j.vaccine.2021.12.042_b0210","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1074-7613(00)80513-0","article-title":"Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles","volume":"7","author":"Doolan","year":"1997","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.vaccine.2021.12.042_b0215","article-title":"Identification and localization of minimal MHC-restricted CD8+ T cell epitopes within the Plasmodium falciparum AMA1 protein","volume":"9","author":"Sedegah","year":"2010","journal-title":"MalarJ."},{"issue":"8956","key":"10.1016\/j.vaccine.2021.12.042_b0220","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0140-6736(95)90754-8","article-title":"Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria","volume":"345","author":"Aidoo","year":"1995","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2021.12.042_b0225","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-014-0539-5","article-title":"Measuring naturally acquired ex vivo IFN-\u03b3 responses to Plasmodium falciparum cell-traversal protein for ookinetes and sporozoites (CelTOS) in Ghanaian adults","volume":"14","author":"Anum","year":"2015","journal-title":"Malar J"},{"issue":"10","key":"10.1016\/j.vaccine.2021.12.042_b0230","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1086\/503364","article-title":"Independence of Granzyme B Secretion and Interferon-\u03b3 Production during Acute Simian Immunodeficiency Virus Infection","volume":"193","author":"Calarota","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.12.042_b0235","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1084\/jem.20022003","article-title":"Inhibition of T cell function during malaria: implications for immunology and vaccinology","volume":"197","author":"Urban","year":"2003","journal-title":"JExpMed."},{"key":"10.1016\/j.vaccine.2021.12.042_b0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002567","article-title":"Impairment of T Cell Function in Parasitic Infections","volume":"8","author":"Rodrigues","year":"2014","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.vaccine.2021.12.042_b0245","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12936-018-2410-6","article-title":"Characterization of T cell activation and regulation in children with asymptomatic Plasmodium falciparum infection","volume":"17","author":"Frimpong","year":"2018","journal-title":"Malar J."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21016509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21016509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:07:43Z","timestamp":1759403263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21016509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0264410X21016509"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.12.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards large-scale identification of HLA-restricted T cell epitopes from four vaccine candidate antigens in a malaria endemic community in Ghana","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.12.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}